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Abstract
Background: Candidemia is a severe fungal infection that primarily affects hospitalized and/or
immunocompromised patients. Mononuclear phagocytes have been recognized as pivotal immune cells which act
in the recognition of pathogens, phagocytosis, inflammation, polarization of adaptive immune response and tissue
repair. Experimental studies have showed that the systemic candidiasis could be controlled by activated peritoneal
macrophages. However, the mechanism to explain how these cells act in distant tissue during a systemic fungal
infection is still to be elucidated. In the present study we investigate the in vivo trafficking of phagocytic peritoneal
cells into infected organs in hypoinsulinemic-hyperglycemic (HH) mice with systemic candidiasis.
Methods: The red fluorescent vital dye PKH-26 PCL was injected into the peritoneal cavity of Swiss mice 24 hours
before the intravenous inoculation with Candida albicans. After 24 and 48 hours and 7 days of infection, samples of
the spleen, liver, kidneys, brain and lungs were submitted to the microbiological evaluation as well as to phagocytic
peritoneal cell trafficking analyses by fluorescence microscopy.
Results: In the present study, PKH+ cells were observed in the peritoneum, kidney, spleen and liver samples from
all groups. In infected mice, we also found PKH+ cells in the lung and brain. The HH condition did not affect this
process.
Conclusions: In the present study we have observed that peritoneal phagocytes migrate to tissues infected by
C. albicans and the HH condition did not interfere in this process.
Background
Systemic fungal infections in general, and of candidemia
in particular, are severe infections that frequently affect
immunocompromised patients including the patients with
diabetes mellitus (DM) which correspond to 13%-21% of
all candidemia episodes [1-3]. Experimental studies have
shown that DM condition increases the susceptibility to
candidiasis [4-6]; however, the immunological mecha-
nisms involved in this process have not been extensively
studied.
Deficiency in the host immune system is the major
predisposing factor to Candida spp infection [7-9].
Macrophages are pivotal immune cells which act in the
recognition of pathogens, phagocytosis, inflammation,
polarization of adaptive immune response and tissue repair.
They are deeply involved in the control and/or eradication
of Candida infections [10,11].
Conchon-Costa et al. [12] demonstrated the possibility
of controlling systemic candidiasis by activated peritoneal
macrophages in the experimental model of Concanavalin
A (ConA)-treated mice, using intraperitoneal route during
systemic candidiasis. The researchers observed a decrease
of the mortality of treated-mice challenged with a lethal
dose of Candida albicans. This event was associated with
increased TNF-α production, mannose receptor expression
and candidacidal activity by peritoneal cells [12,13].
The participation of activated peritoneal cells in distant in-
fections and/or inflammation has been suggested for some
time. The migration of cells between the peritoneal cavity
and inflamed [14-17], infected [16], neoplastic [18] and adi-
pose tissues [19] have been demonstrated. Considering
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that the peritoneal cavity serves as an alternative site
for immunotherapeutic procedures, the present study in-
vestigates the possibility that peritoneal phagocytes migrate
to tissues infected by fungi. Because fungal infections are
more frequent and difficult to remission in patients
with DM, we also investigated the possibility that the
hypoinsulinemic-hyperglycemic (HH) condition affects
the peritoneal cell trafficking. According to our know-
ledge, this is the first study to explore migrating peri-
toneal phagocytes during systemic candidiasis.
Methods
Mice
Forty-five-day old male Swiss and C57Bl/6 mice from the
Animal House of the Laboratório de Imunopatologia
Experimental (LIPE), Departamento de Ciências Biológicas,
Faculdade de Ciências, UNESP – Univ Estadual Paulista
were used for the experiments. The animals received
balanced diet and water ad libitum. All procedures were
performed in accordance to the ethical standards
established by the Brazilian College of Animal Experimen-
tation (Colégio Brasileiro de Experimentação Animal -
COBEA) and approved by the Committee for Ethics in
Animal Experimentation of the Faculdade de Ciências –
UNESP/Bauru.
Fungi
C. albicans strain FCF 14 was originally obtained from
the mycology collection of the Faculdade de Odontologia
de Guaratinguetá, UNESP – Univ Estadual Paulista and
was maintained in our mycological collections on
Sabouraud dextrose agar (Difco Laboratories, Detroit,
Michigan, USA) and monthly samplings in Sabouraud-
dextrose medium.
Experimental design
Sixty Swiss mice were distributed into 4 groups: Group
Ca, which was composed of 18 C. albicans-infected
mice; Group HH-Ca, composed of 18 HH-induced and
C. albicans-infected mice; Group HH, composed of 18
HH-induced mice; and Control Group (CTL), composed
of 6 free HH-induced and non-infected mice which were
subjected to the same inoculation procedures using
sterile saline solution (SSS).
Induction of the HH condition
Alloxan administration in laboratory animals selectively
destroys the insulin-producing pancreatic β-cells [20].
Mice were intravenously inoculated by alloxan (Sigma
Chemical Co., St. Louis, MO, USA) in a single dose of 60
mg kg-1 of body weight into the caudal vein. Hyperglycemia
was confirmed 48 hours (h) later using Accu-Check
Advantage II blood glucose test strips (Roche, Mannheim,
Germany). Only mice showing blood glucose levels
200 mg dl-1 were considered HH and included in the
experiment. The glucose levels during the experiment
were typically 400–600 mg dl-1 in HH mice. Control mice
(Ca and CTL groups) were treated identically with a
sterile saline solution and presented serum glucose levels
ranging from 90 to 130 mg dl-1.
Induction of systemic candidiasis
The C. albicans inoculum was obtained from a fungal
suspension as previously described [21]. The fungal
concentration was adjusted to 5.0 × 107 viable C.
albicans ml-1. The C. albicans suspension has been inocu-
lated into the lateral tail vein. Mice of the Ca and HH-Ca
groups were inoculated with 0.1 ml of this suspension
and, in the HH-Ca groups the mice were inoculated two
days after HH induction. Tests previously performed in
our lab demonstrated that this inoculums size is not lethal
in naïve Swiss mice and it reproduces a systemic fungal
infection (data not shown).
Determination of peritoneal cellular trafficking
Direct injection of PKH-26 PCL into the peritoneal cavity
Peritoneal phagocytes were labeled with the fluorescent
vital dye PKH-26 PCL in accordance with the manufac-
turer’s protocol (Sigma). Briefly, 2.0 × 10-6 M PKH-26 PCL
was diluted in the diluents B and 24 h before to the fungal
inoculation, 0.1 ml of the PKH-26 PCL use solution was
injected into the peritoneal cavity of each mouse.
Adoptive cell transfer assay
In order to confirm the peritoneal cells migration, we
have used the adoptive cell transfer assay. As the Swiss
mice are outbred strain, we have employed C57BL/6
inbred mice to perform the experiments as cell donor
and recipient mice. A peritoneal lavage (PL) was
performed in the donor mice, and the harvested cells
were stained with PKH-26 PCL using the protocol
according the previous item. After 30 minutes, the
samples were centrifuged at 1500 rpm for 5 minutes and
washed extensively with cold and sterile phosphate
buffered saline (PBS). Naïve recipient mice were then
intraperitoneally inoculated with 2 × 106 PKH+ cells.
After 24 h, these mice were intravenously challenged
with 5 × 106 C. albicans and subsequently analyzed
24 h, 48 h and 7 days after the fungal inoculation.
Collection of biological samples
The mice were euthanized by carbon dioxide inhalation
(CO2) 24 h, 48 h or 7 days after the fungal inoculation.
PL was performed with cold and sterile PBS. To confirm
the presence of PKH+ cells in the PL samples, smears
were prepared with 0.1 ml of the sample. Spleen, brain,
liver, lung and kidney samples were also collected from
the euthanized mice.
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Imprint
Using a scalpel, vertical sections were made on the tissues
selected for the study. The pieces were pressed against
glass slides and allowed to dry at room temperature. After
washing them with PBS, the imprinted slides were
mounted using Fluoroshield™ with DAPI (Sigma). The
slides were analyzed with a fluorescence microscope
(BX61, Olympus Optical, Tokyo, Japan). Following the
identification of the migrating cells, the slides were
subjected to confocal laser scanning microscopy analysis
(TCS-SPE, Leica Microsystems, Mannheim, Germany),
and images were captured using Leica LAS-AF Software.
Determination of fungal load
The spleen, brain, liver, lung, kidney and PL samples
were submitted to microbiological evaluation in order to
determine the fungal load. After collection, the samples
were weighed and macerated in 1.0 ml of sterile PBS. A
volume of 0.1 ml was spread over culture plates
containing Sabouraud-dextrose agar using a Drigalski T
loop. The procedures were performed in duplicate. The
plates were then sealed and incubated at 37°C for 3 days.
The number of colony forming units (CFU) was normalized
per gram of tissue.
Statistical analyses
Statistical tests were performed using SigmaPlot Software
version 12.0 for Windows (1995, Jandel Corporation, San
Rafael, CA, USA), and the significance level established to
verify the null hypothesis was 5.0%. The data passed in
normality test (Shapiro-Wilk) and the comparison of two
independent samples was analyzed using a t test [22].
Results
HH condition leads to an increase of fungal load
The intravenous inoculation of C. albicans resulted in
acute systemic dissemination affecting the kidney,
spleen, liver, lung and brain. The HH condition did not
affect the distribution of the fungi at 24 h and 48 h.
However, on day 7, the mice of HH-Ca group exhibited
higher fungal load in the liver than Ca group (Figure 1).
Systemic infection by C. albicans enhances the spreading
of labeled peritoneal phagocyte to infected tissue
Several methods have been used to determine cell
trafficking such as adoptive cell transfer [14-16],
ex vivo assays [19], cryogenic tissue evaluation [18,19]
and flow cytometry [14,17,19,23]. In the preset study
we used the PKH-26 PCL as tracing cell marker and
imprinting technique to evaluate the migration of labeled
cells. The vital fluorescent dye PKH-26 PCL provides
strong fluorescence without causing functional damage to
the cell. This dye induces the formation of aggregates,
which allows the identification of phagocytic cells, such as
Figure 1 Determination of fungal load in the Ca and HH-Ca
groups. The results are expressed as CFU (log10) per gram of tissue
(t test; p < 0.05; n = 6/group and experimental moment).
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Figure 2 Trafficking of peritoneal cells during systemic candidiasis. Male Swiss mice were previously inoculated by intraperitoneal route
with the fluorescent dye PKH-26 PCL and after 24 hours, the mice were intravenously challenged with 5 x 106 C. albicans. After 24 and 48 hours
and 7 days, the mice were euthanized and samples of peritoneal cells, brain, liver, kidney, lung and spleen were subjected to fluorescence
analysis. PKH-26 PCL: red; DAPI: blue.
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macrophages and neutrophils. Several studies have used
PKH-26 PCL for selective tracing of peritoneal phagocytes
without staining phagocytes from other tissues or
blood stream [24-27]. We previously performed some
experiments to evaluate the PHK-26 PCL staining in
frozen tissue sections and we observed more artifacts and
lower fluorescence intensity than in fresh samples
obtained from imprinting techniques (data not shown).
In the present study, PKH+ cells were observed in the
peritoneum, kidney, spleen and liver samples (Figure 2)
from all groups, including the group of non-infected
animals (HH and CTL groups). In the HH-Ca and Ca
groups, PKH+ cells were also found both in the lung and
brain. In the HH group, we observed no PKH+cells in
the brain and in the CTL group, no PKH+cells in the
lung. The cellular adoptive transfer assay confirmed the
migration of PKH+ cells from the peritoneal cavity to all
of the infected tissues at all of the time points analyzed
in the present study (data not shown).
Furthermore, we observed morphological heterogeneity
among migratory labeled cells (Figure 2).
Discussion
The murine model for disseminated infection by C.
albicans has been well characterized [28-30]. When
fungal cells are intravenously inoculated by lateral tail
vein, the fungus spreads rapidly, mimicking the infection
that occurs when fungal cells enter the blood stream
through the gastrointestinal tract, or an intravenous
catheter. In our infected-mice, as previously described in
non-progressive Candida hematogenous infection, the
infection is controlled in the majority of the tissues,
including the liver, spleen, heart and lungs but advances
in the kidney and brain [30,31]. Here, we have amplified
these findings using HH mice induced by alloxan. The
choice of alloxan-induced HH mice has two rationales.
The first one is due to DM represent an important im-
port underlying disease in episodes of candidemia (13-
21%) [1-3], and the second is because this condition inter-
feres in the animal defense mechanisms, therefore making
possible the study of the immunological alterations in-
volved in the infections which undertake the patients with
DM. In addition, the alloxan model, when used in the first
hours after drug inoculation, mimics only the HH condi-
tion of DM and not the chronic disturbs; as a conse-
quence, the data interpretation is specific to this
abnormality. Our data has demonstrated an increase in
the fungal load in the tissues of HH-mice (particularly the
liver) 7 days after the inoculation. A larger fungal load has
also been observed in the tissues of diabetic mice
Mosci et al. [4], with an increased load which has been
particularly prevalent in the liver of the HH-mice. The
data reinforces the idea that the HH condition increases
susceptibility to systemic candidiasis and suggests that this
model could be an interesting option for investigating
different aspects of this infection.
Several studies have shown that macrophages in a
microenvironment rich in glucose exhibit diverse
functional alterations, such as increased oxidative stress
and enhanced transcription genes encoding for cytokines,
growth factors and adhesive molecules [32]. These
alterations have been triggered by increased formation of
the advanced glycation end products (AGEs) [33].
Considering that the hyperglycemia affects the metabolism
of these cells, we have come to the idea that other cellular
alterations could be occurring which could affect the
migration of these cells. We have identified an enhance
in the spread of migratory peritoneal phagocytes during
systemic candidiasis in naïve mice and that the HH
condition did not interfere in this process. For this
identification we have used the imprinting technique
associated with PKH-26 PCL. The analysis of the peritoneal
cell migration is not limited to these two methods.
The PKH is an extensively used supply for cell tracking
protocols [26,27,34], which could be used associated with
other methodologies such as flow cytometry and
two-photon excitation microscopy. The use of transgenic
mouse line with fluorescent protein-labeled is another
sophisticated methodology [35]. The imprinting is a
simple methodology, routinely used for diagnostic in other
situations, as in the evaluation of sentinel lymph nodes for
lobular carcinoma of the breast cancer [36]. Several
studies have demonstrated that the imprinting is superior
to freezing, particularly in cases where the preservation of
the tissue structure is not required [37-40]. Here, we have
observed that imprinting provides a higher-quality analysis
of a larger number of cells than the cryogenic sectioning
and it is an interesting option for screening cell trafficking
due to an easily and faster methodology.
Conclusions
In summary, our results reinforce the migratory capacity
of the peritoneal cells and demonstrate that the HH
condition does not alter this process, enabling the use of
the peritoneal cavity in immunotherapeutic approaches.
Immunotherapy from this site has been considered a
viable and promising alternative. This route has been
used to immunize mice with ex vivo-treated dendritic
cells for prostate cancer intervention [41]. Experimen-
tally, ConA has been used to stimulate the peritoneal
cell [12]; they have observed increased survival rate
during lethal C. albicans hematogenous infection. Thus,
even in patients with DM, the peritoneal cavity can be
used for immunotherapeutic intervention, i.e., as a site
for stimulating and macrophages to migrate from the
peritoneum to the compromised tissues and to modulate
the infectious process.
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